Cognetivity Neurosciences Ltd. operates as a technology company. The company is headquartered in Vancouver, British Columbia. The firm has developed a cognitive testing platform, the Integrated Cognitive Assessment (ICA), for use in medical and commercial environments and other neurological conditions. The Company’s CognICA uses artificial intelligence and machine learning technology to test the performance of large areas of the brain to help detect early signs of cognitive dysfunction. The company is also focused on developing the ICA for home use, for the remote monitoring of patient’s progress under treatment regimens and for general home healthcare check-ups. CognICA is available for clinical use in the United States, United Kingdom, Europe, Canada and the Middle East. Its subsidiaries include Cognetivity Ltd. and Cognetivity FZ-LLC.
Follow-Up Questions
Qui est le CEO de Cognetivity Neurosciences Ltd ?
Dr. Sina Habibi est le Chief Executive Officer de Cognetivity Neurosciences Ltd, il a rejoint l'entreprise depuis 2017.
Quelle est la performance du prix de l'action CGNSF ?
Le prix actuel de CGNSF est de $0, il a decreased de 0% lors de la dernière journée de trading.
Quels sont les thèmes d'affaires principaux ou les industries de Cognetivity Neurosciences Ltd ?
Cognetivity Neurosciences Ltd appartient à l'industrie N/A et le secteur est N/A
Quelle est la capitalisation boursière de Cognetivity Neurosciences Ltd ?
La capitalisation boursière actuelle de Cognetivity Neurosciences Ltd est de $0
Est-ce que Cognetivity Neurosciences Ltd est un achat, une vente ou un maintien ?
Selon les analystes de Wall Street, 3 analystes ont établi des notations d'analystes pour Cognetivity Neurosciences Ltd, y compris 1 achat fort, 3 achat, 1 maintien, 0 vente et 1 vente forte
